Setback for Novartis as Chandrasekaran stays

Posted on July 21st, 2007 by admin

Economic Times, July 21, 2007
The Indian Patent Appellate Board (IPAB) has dismissed Novartis objection to the appointment of S Chandrasekaran, former Patent Controller General India, to hear its appeal for Glivec.Novartis had filed a petition with IPAB last month, insisting that the newly appointed technical member to the board had in a different capacity refused [...]

No Comments »
Filed under: News

Health organisations urge Novartis to drop patent case

Posted on July 18th, 2007 by admin

Business line Wednesday, Jan 31, 2007
New Delhi Jan. 30 Health organisations from across the world have came forth in support of the Indian Government in its ongoing legal case against drug manufacturer Novartis and urged the Swiss company to drop its patent case in India.
Novartis had filed an application for patenting its cancer drug [...]

No Comments »
Filed under: News, Patent Litigation

IPAB hears Novartis objection against S Chandrasekaran

Posted on July 7th, 2007 by admin

Economic times, July3, 2007
The Indian Patent Appellate Board (IPAB) on Monday heard a case that will decide whether S Chandrasekaran, former controller general of patents, will be allowed to hear Novartis appeal for Glivec, or if a new person will be appointed for the case.

The Swiss drug major had earlier objected to the appointment of [...]

No Comments »
Filed under: News, Patent Litigation

  • Boycott Novartis is a campaign undertaken by the DRUG ACTION FORUM, India against Novartis, a pharmaceutical company dedicated to establishing a patent protected market in India, by the removal of barriers to competition. We are against Novartis patents, one pertaining specifically to access to treatment for thousands of patients suffering from Chronic Myeloid Leukemia (CML) and the other to a broader issue of the cost of new medicines that may be provided Patent protection.

  • Boycott Novartis
    ↑ Subscribe to this feed